Paul Capital Partners

Paul Capital Partners - New York, NY; manages about $5 billion in equity capital commitments, including over $600 million in the healthcare and biotechnology areas.

Related product monographs:

1. Factor VIII, rDNA, new/Wyeth -- Tech.
2. Rotavirus Vaccine, live/GSK -- Tech.
3. Rotavirus Vaccine, live/Merck -- Tech.

Location - New York NY USA

Further information:
Description, ordering information, etc.
Order/Inquiry
Products Database

Copyright ©2020. Biotechnology Information Institute